0 |
URTICARIA |
950 |
1 |
NAUSEA |
728 |
2 |
VOMITING |
633 |
3 |
PRURITUS |
529 |
4 |
DYSPNOEA |
317 |
5 |
ERYTHEMA |
267 |
6 |
RASH |
166 |
7 |
HEADACHE |
156 |
8 |
DIZZINESS |
154 |
9 |
COUGH |
147 |
10 |
SNEEZING |
111 |
11 |
THROAT IRRITATION |
110 |
12 |
FEELING HOT |
108 |
13 |
ANAPHYLACTIC REACTION |
104 |
14 |
CONTRAST MEDIA REACTION |
99 |
15 |
PARAESTHESIA |
94 |
16 |
BURNING SENSATION |
82 |
17 |
EYE SWELLING |
82 |
18 |
THROAT TIGHTNESS |
82 |
19 |
GADOLINIUM DEPOSITION DISEASE |
78 |
20 |
PAIN |
78 |
21 |
CHEST DISCOMFORT |
76 |
22 |
FLUSHING |
75 |
23 |
ARTHRALGIA |
74 |
24 |
HYPERHIDROSIS |
71 |
25 |
HYPERSENSITIVITY |
67 |
26 |
SWELLING FACE |
66 |
27 |
HYPOTENSION |
63 |
28 |
CONTRAST MEDIA ALLERGY |
62 |
29 |
MALAISE |
62 |
30 |
PAIN IN EXTREMITY |
60 |
31 |
FEELING ABNORMAL |
57 |
32 |
OFF LABEL USE |
57 |
33 |
FATIGUE |
55 |
34 |
CHEST PAIN |
54 |
35 |
ASTHENIA |
52 |
36 |
HYPOAESTHESIA |
51 |
37 |
LIP SWELLING |
51 |
38 |
DRUG INEFFECTIVE |
48 |
39 |
DYSPHAGIA |
48 |
40 |
DEATH |
47 |
41 |
NONTHERAPEUTIC AGENT URINE POSITIVE |
47 |
42 |
ANXIETY |
45 |
43 |
PRODUCT USE ISSUE |
45 |
44 |
TREMOR |
45 |
45 |
LOSS OF CONSCIOUSNESS |
44 |
46 |
BONE PAIN |
43 |
47 |
EYE PRURITUS |
43 |
48 |
CARDIAC ARREST |
41 |
49 |
MYALGIA |
41 |
50 |
NASAL CONGESTION |
41 |
51 |
PRURITUS GENERALISED |
37 |
52 |
UNRESPONSIVE TO STIMULI |
37 |
53 |
CONTRAST MEDIA DEPOSITION |
36 |
54 |
RASH ERYTHEMATOUS |
35 |
55 |
ABDOMINAL PAIN |
34 |
56 |
DIARRHOEA |
34 |
57 |
MUSCLE SPASMS |
34 |
58 |
MUSCLE TWITCHING |
34 |
59 |
OCULAR HYPERAEMIA |
34 |
60 |
SEIZURE |
33 |
61 |
PALPITATIONS |
32 |
62 |
TINNITUS |
32 |
63 |
DYSGEUSIA |
31 |
64 |
SWELLING |
31 |
65 |
WHEEZING |
31 |
66 |
SYNCOPE |
30 |
67 |
DYSPHONIA |
29 |
68 |
GAIT DISTURBANCE |
29 |
69 |
RASH MACULAR |
29 |
70 |
VISUAL IMPAIRMENT |
29 |
71 |
PALLOR |
28 |
72 |
SWOLLEN TONGUE |
28 |
73 |
TACHYCARDIA |
27 |
74 |
ALOPECIA |
26 |
75 |
CHILLS |
26 |
76 |
ANAPHYLACTIC SHOCK |
25 |
77 |
BLOOD PRESSURE DECREASED |
25 |
78 |
DISEASE PROGRESSION |
25 |
79 |
HYPERTENSION |
25 |
80 |
PHARYNGEAL OEDEMA |
25 |
81 |
SKIN BURNING SENSATION |
25 |
82 |
DISTURBANCE IN ATTENTION |
24 |
83 |
HEART RATE INCREASED |
24 |
84 |
INSOMNIA |
24 |
85 |
RETCHING |
24 |
86 |
VISION BLURRED |
24 |
87 |
MUSCULAR WEAKNESS |
23 |
88 |
ADVERSE EVENT |
22 |
89 |
EMOTIONAL DISTRESS |
22 |
90 |
PERIPHERAL SWELLING |
22 |
91 |
RESPIRATORY DISTRESS |
22 |
92 |
COGNITIVE DISORDER |
21 |
93 |
LACRIMATION INCREASED |
21 |
94 |
PRESYNCOPE |
21 |
95 |
BLOOD PRESSURE INCREASED |
20 |
96 |
CONFUSIONAL STATE |
20 |
97 |
CONTRAST MEDIA TOXICITY |
20 |
98 |
DRUG HYPERSENSITIVITY |
20 |
99 |
RASH GENERALISED |
20 |
100 |
UNEVALUABLE EVENT |
20 |
101 |
ABDOMINAL DISCOMFORT |
19 |
102 |
ASTHMA |
19 |
103 |
BACK PAIN |
19 |
104 |
OROPHARYNGEAL DISCOMFORT |
19 |
105 |
PULMONARY OEDEMA |
19 |
106 |
PYREXIA |
19 |
107 |
CARDIO-RESPIRATORY ARREST |
18 |
108 |
DRY EYE |
17 |
109 |
INJECTION SITE PAIN |
17 |
110 |
PARAESTHESIA ORAL |
17 |
111 |
SPEECH DISORDER |
17 |
112 |
HYPOAESTHESIA ORAL |
16 |
113 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
16 |
114 |
MITOCHONDRIAL TOXICITY |
16 |
115 |
NEPHROGENIC SYSTEMIC FIBROSIS |
16 |
116 |
ABDOMINAL PAIN UPPER |
15 |
117 |
HOT FLUSH |
15 |
118 |
MEMORY IMPAIRMENT |
15 |
119 |
MUSCLE TIGHTNESS |
15 |
120 |
RESPIRATORY FAILURE |
15 |
121 |
SENSORY DISTURBANCE |
15 |
122 |
URINE ANALYSIS ABNORMAL |
15 |
123 |
CYTOKINE INCREASED |
14 |
124 |
MYOCARDIAL INFARCTION |
14 |
125 |
RENAL PAIN |
14 |
126 |
RESPIRATORY ARREST |
14 |
127 |
TOXICITY TO VARIOUS AGENTS |
14 |
128 |
AGITATION |
13 |
129 |
CYANOSIS |
13 |
130 |
DRY MOUTH |
13 |
131 |
EYE IRRITATION |
13 |
132 |
FALL |
13 |
133 |
HYPOXIA |
13 |
134 |
OXYGEN SATURATION DECREASED |
13 |
135 |
SALIVARY HYPERSECRETION |
13 |
136 |
SKIN DISORDER |
13 |
137 |
ANGIOEDEMA |
12 |
138 |
COLD SWEAT |
12 |
139 |
DECREASED APPETITE |
12 |
140 |
EAR PRURITUS |
12 |
141 |
GENERALISED ERYTHEMA |
12 |
142 |
MUSCLE CONTRACTIONS INVOLUNTARY |
12 |
143 |
MUSCULOSKELETAL STIFFNESS |
12 |
144 |
OEDEMA PERIPHERAL |
12 |
145 |
ORAL DISCOMFORT |
12 |
146 |
PRODUCT USE COMPLAINT |
12 |
147 |
SENSATION OF FOREIGN BODY |
12 |
148 |
SKIN DISCOLOURATION |
12 |
149 |
SKIN WARM |
12 |
150 |
ACUTE KIDNEY INJURY |
11 |
151 |
BLOOD CREATININE INCREASED |
11 |
152 |
CONJUNCTIVITIS |
11 |
153 |
DEPRESSION |
11 |
154 |
DISORIENTATION |
11 |
155 |
HEAD DISCOMFORT |
11 |
156 |
INFLUENZA LIKE ILLNESS |
11 |
157 |
INJECTION SITE ERYTHEMA |
11 |
158 |
INJURY |
11 |
159 |
NECK PAIN |
11 |
160 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
161 |
RENAL FAILURE |
11 |
162 |
SHOCK |
11 |
163 |
SOMNOLENCE |
11 |
164 |
TASTE DISORDER |
11 |
165 |
BALANCE DISORDER |
10 |
166 |
CYTOKINE RELEASE SYNDROME |
10 |
167 |
DISCOMFORT |
10 |
168 |
DYSPEPSIA |
10 |
169 |
EYE PAIN |
10 |
170 |
EYELID OEDEMA |
10 |
171 |
HEART RATE DECREASED |
10 |
172 |
MENTAL IMPAIRMENT |
10 |
173 |
MOBILITY DECREASED |
10 |
174 |
ORAL PRURITUS |
10 |
175 |
RASH PRURITIC |
10 |
176 |
RESPIRATORY DISORDER |
10 |
177 |
RHINORRHOEA |
10 |
178 |
VOMITING PROJECTILE |
10 |
179 |
ARRHYTHMIA |
9 |
180 |
FACE OEDEMA |
9 |
181 |
IMPAIRED WORK ABILITY |
9 |
182 |
JOINT STIFFNESS |
9 |
183 |
NASAL PRURITUS |
9 |
184 |
RASH PAPULAR |
9 |
185 |
SKIN HYPERTROPHY |
9 |
186 |
VERTIGO |
9 |
187 |
ADVERSE DRUG REACTION |
8 |
188 |
APHASIA |
8 |
189 |
CHOKING SENSATION |
8 |
190 |
CONVULSION |
8 |
191 |
DRY THROAT |
8 |
192 |
LETHARGY |
8 |
193 |
NERVOUSNESS |
8 |
194 |
NEUROTOXICITY |
8 |
195 |
OROPHARYNGEAL PAIN |
8 |
196 |
PHARYNGEAL SWELLING |
8 |
197 |
PNEUMONIA |
8 |
198 |
PULSE ABSENT |
8 |
199 |
SKIN TIGHTNESS |
8 |
200 |
TACHYPNOEA |
8 |
201 |
ABDOMINAL DISTENSION |
7 |
202 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
7 |
203 |
AMNESIA |
7 |
204 |
BRADYCARDIA |
7 |
205 |
BRONCHOSPASM |
7 |
206 |
CARDIOVASCULAR DISORDER |
7 |
207 |
COMA |
7 |
208 |
DEHYDRATION |
7 |
209 |
DRY SKIN |
7 |
210 |
EXTRAVASATION |
7 |
211 |
FEELING COLD |
7 |
212 |
INCORRECT DOSE ADMINISTERED |
7 |
213 |
INJECTION SITE EXTRAVASATION |
7 |
214 |
MIGRAINE |
7 |
215 |
MUSCULOSKELETAL CHEST PAIN |
7 |
216 |
NEUROPATHY PERIPHERAL |
7 |
217 |
OVERDOSE |
7 |
218 |
PRODUCT QUALITY ISSUE |
7 |
219 |
PRODUCTIVE COUGH |
7 |
220 |
URINARY INCONTINENCE |
7 |
221 |
WEIGHT DECREASED |
7 |
222 |
BLISTER |
6 |
223 |
BLOOD GLUCOSE INCREASED |
6 |
224 |
CONDITION AGGRAVATED |
6 |
225 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
6 |
226 |
DISSEMINATED INTRAVASCULAR COAGULATION |
6 |
227 |
DYSARTHRIA |
6 |
228 |
EAR SWELLING |
6 |
229 |
ENCEPHALOPATHY |
6 |
230 |
EYE MOVEMENT DISORDER |
6 |
231 |
FOAMING AT MOUTH |
6 |
232 |
GENERAL PHYSICAL HEALTH DETERIORATION |
6 |
233 |
HEMIANAESTHESIA |
6 |
234 |
INFUSION SITE EXTRAVASATION |
6 |
235 |
INJECTION SITE RASH |
6 |
236 |
INJECTION SITE SWELLING |
6 |
237 |
LIMB DISCOMFORT |
6 |
238 |
MUSCLE ATROPHY |
6 |
239 |
MUSCULOSKELETAL PAIN |
6 |
240 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
6 |
241 |
PULSE ABNORMAL |
6 |
242 |
QUALITY OF LIFE DECREASED |
6 |
243 |
RENAL IMPAIRMENT |
6 |
244 |
RESPIRATORY TRACT CONGESTION |
6 |
245 |
SEPSIS |
6 |
246 |
SINUS CONGESTION |
6 |
247 |
SKIN TEST POSITIVE |
6 |
248 |
SWELLING OF EYELID |
6 |
249 |
THIRST |
6 |
250 |
ACCIDENTAL EXPOSURE TO PRODUCT |
5 |
251 |
ADVERSE REACTION |
5 |
252 |
BLOOD HEAVY METAL INCREASED |
5 |
253 |
CEREBROVASCULAR ACCIDENT |
5 |
254 |
DEAFNESS |
5 |
255 |
DIPLOPIA |
5 |
256 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
257 |
DYSKINESIA |
5 |
258 |
DYSSTASIA |
5 |
259 |
ECONOMIC PROBLEM |
5 |
260 |
EOSINOPHILIA |
5 |
261 |
ERYTHEMA MULTIFORME |
5 |
262 |
FACIAL PAIN |
5 |
263 |
FINE MOTOR SKILL DYSFUNCTION |
5 |
264 |
INJECTION RELATED REACTION |
5 |
265 |
INJECTION SITE WARMTH |
5 |
266 |
JOINT SWELLING |
5 |
267 |
LARYNGEAL OEDEMA |
5 |
268 |
MENTAL STATUS CHANGES |
5 |
269 |
METABOLIC ACIDOSIS |
5 |
270 |
MUSCULOSKELETAL DISORDER |
5 |
271 |
NERVOUS SYSTEM DISORDER |
5 |
272 |
NEURALGIA |
5 |
273 |
NONTHERAPEUTIC AGENT BLOOD POSITIVE |
5 |
274 |
PAIN IN JAW |
5 |
275 |
PAIN OF SKIN |
5 |
276 |
PANCREATITIS |
5 |
277 |
PANIC REACTION |
5 |
278 |
PERICARDIAL EFFUSION |
5 |
279 |
PERIPHERAL COLDNESS |
5 |
280 |
SCLERODERMA |
5 |
281 |
SKIN EXFOLIATION |
5 |
282 |
SKIN REACTION |
5 |
283 |
TENSION HEADACHE |
5 |
284 |
TONGUE DISORDER |
5 |
285 |
ACIDOSIS |
4 |
286 |
ALTERED STATE OF CONSCIOUSNESS |
4 |
287 |
ANAEMIA |
4 |
288 |
ATRIAL FIBRILLATION |
4 |
289 |
CARDIAC DISORDER |
4 |
290 |
CHRONIC KIDNEY DISEASE |
4 |
291 |
EAR PAIN |
4 |
292 |
FEBRILE NEUTROPENIA |
4 |
293 |
FORMICATION |
4 |
294 |
GENERALISED TONIC-CLONIC SEIZURE |
4 |
295 |
HEART RATE IRREGULAR |
4 |
296 |
HEPATIC CIRRHOSIS |
4 |
297 |
HEPATOMEGALY |
4 |
298 |
HYPERAESTHESIA |
4 |
299 |
HYPERBILIRUBINAEMIA |
4 |
300 |
ILLNESS |
4 |
301 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
4 |
302 |
INJECTION SITE PRURITUS |
4 |
303 |
LIVER DISORDER |
4 |
304 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
305 |
MEDICATION RESIDUE PRESENT |
4 |
306 |
METAL POISONING |
4 |
307 |
MUSCULOSKELETAL DISCOMFORT |
4 |
308 |
NASOPHARYNGITIS |
4 |
309 |
NO ADVERSE EVENT |
4 |
310 |
OEDEMA MOUTH |
4 |
311 |
OSTEOPENIA |
4 |
312 |
PARALYSIS |
4 |
313 |
PELVIC PAIN |
4 |
314 |
PHOTOPHOBIA |
4 |
315 |
POLLAKIURIA |
4 |
316 |
PULSELESS ELECTRICAL ACTIVITY |
4 |
317 |
SEIZURE LIKE PHENOMENA |
4 |
318 |
SEPTIC SHOCK |
4 |
319 |
STRESS |
4 |
320 |
SUBCUTANEOUS HAEMATOMA |
4 |
321 |
SYRINGE ISSUE |
4 |
322 |
TOOTHACHE |
4 |
323 |
URINARY TRACT INFECTION |
4 |
324 |
VISUAL ACUITY REDUCED |
4 |
325 |
VITREOUS FLOATERS |
4 |
326 |
AGEUSIA |
3 |
327 |
ANAPHYLACTOID REACTION |
3 |
328 |
ANGINA PECTORIS |
3 |
329 |
APHONIA |
3 |
330 |
APNOEA |
3 |
331 |
ASCITES |
3 |
332 |
ATELECTASIS |
3 |
333 |
BEDRIDDEN |
3 |
334 |
BLOOD BILIRUBIN INCREASED |
3 |
335 |
BLOOD CALCIUM DECREASED |
3 |
336 |
BLOOD POTASSIUM DECREASED |
3 |
337 |
BLOOD PRESSURE ABNORMAL |
3 |
338 |
BLOOD TEST ABNORMAL |
3 |
339 |
BLOOD UREA INCREASED |
3 |
340 |
BONE DENSITY DECREASED |
3 |
341 |
BONE LOSS |
3 |
342 |
BRAIN INJURY |
3 |
343 |
BRAIN OEDEMA |
3 |
344 |
CARDIOPULMONARY FAILURE |
3 |
345 |
CELLULITIS |
3 |
346 |
CHOKING |
3 |
347 |
CIRCULATORY COLLAPSE |
3 |
348 |
COAGULOPATHY |
3 |
349 |
CONSTIPATION |
3 |
350 |
CRYING |
3 |
351 |
DELIRIUM |
3 |
352 |
DRUG CLEARANCE DECREASED |
3 |
353 |
DRUG CROSS-REACTIVITY |
3 |
354 |
DRUG SCREEN POSITIVE |
3 |
355 |
DYSURIA |
3 |
356 |
EAR DISCOMFORT |
3 |
357 |
ERYTHEMA OF EYELID |
3 |
358 |
FEAR |
3 |
359 |
FEEDING DISORDER |
3 |
360 |
FLUID OVERLOAD |
3 |
361 |
FOOD INTOLERANCE |
3 |
362 |
GAIT INABILITY |
3 |
363 |
GALLBLADDER ENLARGEMENT |
3 |
364 |
GINGIVAL BLEEDING |
3 |
365 |
GROIN PAIN |
3 |
366 |
HAEMATOCRIT DECREASED |
3 |
367 |
HAEMATURIA |
3 |
368 |
HAEMOGLOBIN DECREASED |
3 |
369 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
370 |
HEPATIC PAIN |
3 |
371 |
HYPOPHAGIA |
3 |
372 |
ILL-DEFINED DISORDER |
3 |
373 |
INCREASED UPPER AIRWAY SECRETION |
3 |
374 |
INFLAMMATION |
3 |
375 |
INFUSION RELATED REACTION |
3 |
376 |
IRRITABILITY |
3 |
377 |
LABORATORY TEST ABNORMAL |
3 |
378 |
LACTIC ACIDOSIS |
3 |
379 |
LEUKOCYTOSIS |
3 |
380 |
LIP PRURITUS |
3 |
381 |
LIVER INJURY |
3 |
382 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
383 |
LOSS OF PROPRIOCEPTION |
3 |
384 |
LUNG DISORDER |
3 |
385 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
386 |
MEDICATION ERROR |
3 |
387 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
3 |
388 |
MITOCHONDRIAL CYTOPATHY |
3 |
389 |
MOUTH SWELLING |
3 |
390 |
MULTIPLE FRACTURES |
3 |
391 |
MUSCLE FATIGUE |
3 |
392 |
MYOSCLEROSIS |
3 |
393 |
NASAL DISCOMFORT |
3 |
394 |
NEUROLOGICAL SYMPTOM |
3 |
395 |
OBSTRUCTIVE AIRWAYS DISORDER |
3 |
396 |
OEDEMA |
3 |
397 |
OSTEONECROSIS |
3 |
398 |
OSTEOPOROSIS |
3 |
399 |
PERIORBITAL OEDEMA |
3 |
400 |
PERIORBITAL SWELLING |
3 |
401 |
PHARYNGEAL DISORDER |
3 |
402 |
PILOERECTION |
3 |
403 |
PLATELET COUNT DECREASED |
3 |
404 |
PNEUMONIA ASPIRATION |
3 |
405 |
PNEUMONITIS |
3 |
406 |
PRODUCT COMPLAINT |
3 |
407 |
RASH MACULO-PAPULAR |
3 |
408 |
RASH PUSTULAR |
3 |
409 |
RED BLOOD CELL COUNT DECREASED |
3 |
410 |
RENAL DISORDER |
3 |
411 |
RESTLESS LEGS SYNDROME |
3 |
412 |
SINUS DISORDER |
3 |
413 |
SINUS TACHYCARDIA |
3 |
414 |
SKIN FIBROSIS |
3 |
415 |
SKIN INDURATION |
3 |
416 |
SKIN LESION |
3 |
417 |
SKIN MASS |
3 |
418 |
SKIN SWELLING |
3 |
419 |
SLEEP DISORDER |
3 |
420 |
SUBARACHNOID HAEMORRHAGE |
3 |
421 |
SUICIDAL IDEATION |
3 |
422 |
THROMBOCYTOPENIA |
3 |
423 |
THROMBOSIS |
3 |
424 |
TONGUE DISCOMFORT |
3 |
425 |
TONGUE PRURITUS |
3 |
426 |
URINARY RETENTION |
3 |
427 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
428 |
ABDOMINAL PAIN LOWER |
2 |
429 |
ABNORMAL SENSATION IN EYE |
2 |
430 |
ACCIDENTAL OVERDOSE |
2 |
431 |
ACNE |
2 |
432 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
2 |
433 |
ACUTE MYOCARDIAL INFARCTION |
2 |
434 |
ACUTE RESPIRATORY FAILURE |
2 |
435 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
436 |
AMMONIA INCREASED |
2 |
437 |
ANION GAP INCREASED |
2 |
438 |
ANTI-ERYTHROCYTE ANTIBODY POSITIVE |
2 |
439 |
ARTHROPATHY |
2 |
440 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
441 |
ASPHYXIA |
2 |
442 |
AZOTAEMIA |
2 |
443 |
BIOPSY SKIN ABNORMAL |
2 |
444 |
BLEPHAROSPASM |
2 |
445 |
BLOOD ALBUMIN DECREASED |
2 |
446 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
2 |
447 |
BLOOD CHLORIDE INCREASED |
2 |
448 |
BLOOD HEAVY METAL ABNORMAL |
2 |
449 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
2 |
450 |
BLOOD MAGNESIUM DECREASED |
2 |
451 |
BLOOD PH INCREASED |
2 |
452 |
BLOOD PHOSPHORUS DECREASED |
2 |
453 |
BLOOD PRESSURE FLUCTUATION |
2 |
454 |
BLOOD PRESSURE SYSTOLIC DECREASED |
2 |
455 |
BLOOD SODIUM INCREASED |
2 |
456 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
457 |
BODY TEMPERATURE DECREASED |
2 |
458 |
BODY TEMPERATURE FLUCTUATION |
2 |
459 |
BONE DISORDER |
2 |
460 |
BRAIN HERNIATION |
2 |
461 |
BRAIN STEM SYNDROME |
2 |
462 |
BREAST PAIN |
2 |
463 |
CALCIUM IONISED DECREASED |
2 |
464 |
CARBON DIOXIDE DECREASED |
2 |
465 |
CARDIAC FAILURE |
2 |
466 |
CARDIAC FLUTTER |
2 |
467 |
CARDIOGENIC SHOCK |
2 |
468 |
CARDIOVASCULAR INSUFFICIENCY |
2 |
469 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
470 |
CEREBRAL INFARCTION |
2 |
471 |
CHROMATURIA |
2 |
472 |
CLONUS |
2 |
473 |
COLITIS ULCERATIVE |
2 |
474 |
CONSCIOUSNESS FLUCTUATING |
2 |
475 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
476 |
CONTRAST ENCEPHALOPATHY |
2 |
477 |
CRAMP-FASCICULATION SYNDROME |
2 |
478 |
DECREASED ACTIVITY |
2 |
479 |
DERMATITIS ATOPIC |
2 |
480 |
DEVICE USE ERROR |
2 |
481 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
2 |
482 |
DOSE CALCULATION ERROR |
2 |
483 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
484 |
DRUG LEVEL INCREASED |
2 |
485 |
DYSPHEMIA |
2 |
486 |
EAR CONGESTION |
2 |
487 |
ECZEMA |
2 |
488 |
EJECTION FRACTION DECREASED |
2 |
489 |
ELECTRIC SHOCK SENSATION |
2 |
490 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
491 |
ELECTROLYTE IMBALANCE |
2 |
492 |
EMERGENCY CARE |
2 |
493 |
END STAGE RENAL DISEASE |
2 |
494 |
EPISTAXIS |
2 |
495 |
EXPIRED PRODUCT ADMINISTERED |
2 |
496 |
EXTRA DOSE ADMINISTERED |
2 |
497 |
EYE DISORDER |
2 |
498 |
EYELIDS PRURITUS |
2 |
499 |
FAECES DISCOLOURED |
2 |
500 |
FIBROSIS |
2 |
501 |
FLANK PAIN |
2 |
502 |
FLATULENCE |
2 |
503 |
FOOT FRACTURE |
2 |
504 |
GALLBLADDER DISORDER |
2 |
505 |
GASTROINTESTINAL DISORDER |
2 |
506 |
GASTROINTESTINAL OEDEMA |
2 |
507 |
GINGIVAL SWELLING |
2 |
508 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
509 |
GLOSSODYNIA |
2 |
510 |
GUILLAIN-BARRE SYNDROME |
2 |
511 |
HAEMANGIOMA OF SKIN |
2 |
512 |
HAEMATEMESIS |
2 |
513 |
HAEMATOCHEZIA |
2 |
514 |
HAEMATOMA |
2 |
515 |
HAEMODIALYSIS |
2 |
516 |
HAEMOPTYSIS |
2 |
517 |
HAEMORRHAGE |
2 |
518 |
HAEMORRHOIDS |
2 |
519 |
HAIR METAL TEST ABNORMAL |
2 |
520 |
HALLUCINATION |
2 |
521 |
HEMIPARESIS |
2 |
522 |
HEPATIC FAILURE |
2 |
523 |
HEPATIC STEATOSIS |
2 |
524 |
HEPATITIS C |
2 |
525 |
HEPATOTOXICITY |
2 |
526 |
HYPERACUSIS |
2 |
527 |
HYPERGLYCAEMIA |
2 |
528 |
HYPERINTENSITY IN BRAIN DEEP NUCLEI |
2 |
529 |
HYPERSENSITIVITY VASCULITIS |
2 |
530 |
HYPERSOMNIA |
2 |
531 |
HYPERTENSIVE CRISIS |
2 |
532 |
HYPERTROPHY |
2 |
533 |
HYPOAESTHESIA EYE |
2 |
534 |
HYPOCALCAEMIA |
2 |
535 |
HYPOKALAEMIA |
2 |
536 |
HYPOTHERMIA |
2 |
537 |
HYPOTONIA |
2 |
538 |
IDIOSYNCRATIC DRUG REACTION |
2 |
539 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
2 |
540 |
IMPAIRED HEALING |
2 |
541 |
IMPAIRED QUALITY OF LIFE |
2 |
542 |
INCOHERENT |
2 |
543 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
544 |
INCREASED TENDENCY TO BRUISE |
2 |
545 |
INFECTION |
2 |
546 |
INJECTION SITE COLDNESS |
2 |
547 |
INJECTION SITE MASS |
2 |
548 |
INTRAOCULAR PRESSURE INCREASED |
2 |
549 |
IRON OVERLOAD |
2 |
550 |
IRRITABLE BOWEL SYNDROME |
2 |
551 |
JAUNDICE |
2 |
552 |
LARYNGOSPASM |
2 |
553 |
LIMB INJURY |
2 |
554 |
LIP DISCOLOURATION |
2 |
555 |
LIPASE INCREASED |
2 |
556 |
LYMPH NODE PAIN |
2 |
557 |
MADAROSIS |
2 |
558 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
2 |
559 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
2 |
560 |
MEAN CELL VOLUME DECREASED |
2 |
561 |
MIDDLE INSOMNIA |
2 |
562 |
MITRAL VALVE INCOMPETENCE |
2 |
563 |
MOVEMENT DISORDER |
2 |
564 |
MYDRIASIS |
2 |
565 |
MYOPATHY |
2 |
566 |
NASAL OEDEMA |
2 |
567 |
NEPHROLITHIASIS |
2 |
568 |
NEUTROPENIA |
2 |
569 |
NONSPECIFIC REACTION |
2 |
570 |
NYSTAGMUS |
2 |
571 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
2 |
572 |
OCULAR DISCOMFORT |
2 |
573 |
ORBITAL OEDEMA |
2 |
574 |
PAINFUL RESPIRATION |
2 |
575 |
PANCREATIC ENLARGEMENT |
2 |
576 |
PANCREATITIS ACUTE |
2 |
577 |
PANIC ATTACK |
2 |
578 |
PARAESTHESIA EAR |
2 |
579 |
PARAESTHESIA MUCOSAL |
2 |
580 |
PERIPHERAL ARTERY OCCLUSION |
2 |
581 |
PHARYNGEAL HYPOAESTHESIA |
2 |
582 |
PHARYNGEAL PARAESTHESIA |
2 |
583 |
PHOTOSENSITIVITY REACTION |
2 |
584 |
PLEURAL EFFUSION |
2 |
585 |
POISONING |
2 |
586 |
POST PROCEDURAL COMPLICATION |
2 |
587 |
PROCEDURAL NAUSEA |
2 |
588 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
589 |
PRODUCT PRESCRIBING ERROR |
2 |
590 |
PRODUCT PRESCRIBING ISSUE |
2 |
591 |
PROTEIN TOTAL DECREASED |
2 |
592 |
PULMONARY EMBOLISM |
2 |
593 |
PULMONARY FIBROSIS |
2 |
594 |
PURPURA |
2 |
595 |
REGURGITATION |
2 |
596 |
RESPIRATORY DEPRESSION |
2 |
597 |
RESTLESSNESS |
2 |
598 |
RHABDOMYOLYSIS |
2 |
599 |
RIB FRACTURE |
2 |
600 |
SCAN WITH CONTRAST |
2 |
601 |
SCAR |
2 |
602 |
SECRETION DISCHARGE |
2 |
603 |
SENSORIMOTOR DISORDER |
2 |
604 |
SERUM FERRITIN INCREASED |
2 |
605 |
SKIN CANDIDA |
2 |
606 |
SKIN HAEMORRHAGE |
2 |
607 |
SKIN HYPERPIGMENTATION |
2 |
608 |
SKIN IRRITATION |
2 |
609 |
SKIN TEXTURE ABNORMAL |
2 |
610 |
SKIN ULCER |
2 |
611 |
SPLENOMEGALY |
2 |
612 |
SPUTUM RETENTION |
2 |
613 |
STRIDOR |
2 |
614 |
SUSPECTED PRODUCT CONTAMINATION |
2 |
615 |
TENDON PAIN |
2 |
616 |
TENSION |
2 |
617 |
TESTICULAR PAIN |
2 |
618 |
TESTICULAR SWELLING |
2 |
619 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
620 |
THINKING ABNORMAL |
2 |
621 |
THROAT CLEARING |
2 |
622 |
TONGUE BITING |
2 |
623 |
TOOTH LOSS |
2 |
624 |
TORTICOLLIS |
2 |
625 |
TRANCE |
2 |
626 |
TRANSAMINASES INCREASED |
2 |
627 |
TUMOUR LYSIS SYNDROME |
2 |
628 |
VASCULAR PAIN |
2 |
629 |
VISUAL FIELD DEFECT |
2 |
630 |
WEIGHT INCREASED |
2 |
631 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
632 |
YAWNING |
2 |
633 |
ABASIA |
1 |
634 |
ABDOMINAL RIGIDITY |
1 |
635 |
ABNORMAL BEHAVIOUR |
1 |
636 |
ABNORMAL FAECES |
1 |
637 |
ABNORMAL LOSS OF WEIGHT |
1 |
638 |
ABORTION SPONTANEOUS |
1 |
639 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
640 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
641 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
642 |
ACUTE CORONARY SYNDROME |
1 |
643 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
644 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1 |
645 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
646 |
ADMINISTRATION SITE REACTION |
1 |
647 |
ADRENAL INSUFFICIENCY |
1 |
648 |
AGONAL RESPIRATION |
1 |
649 |
AGRAPHIA |
1 |
650 |
ALLODYNIA |
1 |
651 |
ALVEOLITIS |
1 |
652 |
ALVEOLITIS ALLERGIC |
1 |
653 |
AMENORRHOEA |
1 |
654 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
1 |
655 |
ANAL SQUAMOUS CELL CARCINOMA |
1 |
656 |
ANHEDONIA |
1 |
657 |
ANORECTAL DISCOMFORT |
1 |
658 |
AORTIC ANEURYSM |
1 |
659 |
AORTIC INTRAMURAL HAEMATOMA |
1 |
660 |
APLASIA PURE RED CELL |
1 |
661 |
APTYALISM |
1 |
662 |
ARTHRITIS |
1 |
663 |
ASPERGILLUS INFECTION |
1 |
664 |
AURA |
1 |
665 |
AUTOIMMUNE ENCEPHALOPATHY |
1 |
666 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
667 |
AXILLARY PAIN |
1 |
668 |
B-CELL APLASIA |
1 |
669 |
BACK DISORDER |
1 |
670 |
BACTERAEMIA |
1 |
671 |
BACTERIAL SEPSIS |
1 |
672 |
BASOPHIL COUNT INCREASED |
1 |
673 |
BILE OUTPUT DECREASED |
1 |
674 |
BILIARY COLIC |
1 |
675 |
BINOCULAR EYE MOVEMENT DISORDER |
1 |
676 |
BIOPSY BRAIN ABNORMAL |
1 |
677 |
BIOPSY THYROID GLAND ABNORMAL |
1 |
678 |
BLINDNESS |
1 |
679 |
BLINDNESS TRANSIENT |
1 |
680 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
681 |
BLOOD CALCIUM INCREASED |
1 |
682 |
BLOOD CORTICOTROPHIN ABNORMAL |
1 |
683 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
684 |
BLOOD GLUCOSE DECREASED |
1 |
685 |
BLOOD HOMOCYSTEINE INCREASED |
1 |
686 |
BLOOD LACTIC ACID INCREASED |
1 |
687 |
BLOOD PRESSURE IMMEASURABLE |
1 |
688 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
689 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
690 |
BLOOD URINE PRESENT |
1 |
691 |
BONE MARROW FAILURE |
1 |
692 |
BOWEN^S DISEASE |
1 |
693 |
BRAIN NEOPLASM |
1 |
694 |
BREAST NECROSIS |
1 |
695 |
BRONCHIAL DISORDER |
1 |
696 |
BRONCHIAL HYPERREACTIVITY |
1 |
697 |
BRONCHIAL SECRETION RETENTION |
1 |
698 |
BRONCHIAL WALL THICKENING |
1 |
699 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
700 |
BUNDLE BRANCH BLOCK LEFT |
1 |
701 |
BURKHOLDERIA INFECTION |
1 |
702 |
BURKHOLDERIA TEST POSITIVE |
1 |
703 |
BURNOUT SYNDROME |
1 |
704 |
BURSITIS INFECTIVE |
1 |
705 |
CALCIPHYLAXIS |
1 |
706 |
CANDIDA INFECTION |
1 |
707 |
CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME |
1 |
708 |
CARDIAC DISCOMFORT |
1 |
709 |
CARDIAC FAILURE CONGESTIVE |
1 |
710 |
CARDIO-RESPIRATORY DISTRESS |
1 |
711 |
CATHETER SITE PAIN |
1 |
712 |
CATHETER SITE PRURITUS |
1 |
713 |
CAVERNOUS SINUS THROMBOSIS |
1 |
714 |
CENTRAL NERVOUS SYSTEM INJURY |
1 |
715 |
CENTRAL NERVOUS SYSTEM NECROSIS |
1 |
716 |
CENTRAL PAIN SYNDROME |
1 |
717 |
CEREBRAL ARTERY PERFORATION |
1 |
718 |
CEREBRAL CYST |
1 |
719 |
CEREBRAL DISORDER |
1 |
720 |
CERVICAL CORD COMPRESSION |
1 |
721 |
CHEMICAL BURN OF SKIN |
1 |
722 |
CHEMOTHERAPY |
1 |
723 |
CHOLECYSTITIS |
1 |
724 |
CHOLECYSTITIS ACUTE |
1 |
725 |
CHOLECYSTITIS INFECTIVE |
1 |
726 |
CHOLELITHIASIS |
1 |
727 |
CHOLESTASIS |
1 |
728 |
CIRCUMORAL OEDEMA |
1 |
729 |
CLAUSTROPHOBIA |
1 |
730 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
731 |
COLITIS |
1 |
732 |
COLLAGEN DISORDER |
1 |
733 |
COLONOSCOPY |
1 |
734 |
COMMUNICATION DISORDER |
1 |
735 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
736 |
CONGENITAL BLADDER ANOMALY |
1 |
737 |
CONGENITAL GASTRIC ANOMALY |
1 |
738 |
CONJUNCTIVAL OEDEMA |
1 |
739 |
CONNECTIVE TISSUE DISORDER |
1 |
740 |
CONTUSION |
1 |
741 |
COSTOCHONDRITIS |
1 |
742 |
COVID-19 |
1 |
743 |
CUTANEOUS SARCOIDOSIS |
1 |
744 |
CYSTITIS |
1 |
745 |
CYSTITIS NONINFECTIVE |
1 |
746 |
CYTOKINE STORM |
1 |
747 |
CYTOMEGALOVIRUS INFECTION |
1 |
748 |
DEAFNESS BILATERAL |
1 |
749 |
DEAFNESS UNILATERAL |
1 |
750 |
DECREASED INTEREST |
1 |
751 |
DEEP VEIN THROMBOSIS |
1 |
752 |
DEGENERATIVE BONE DISEASE |
1 |
753 |
DEPENDENCE ON RESPIRATOR |
1 |
754 |
DEPRESSED MOOD |
1 |
755 |
DERMATITIS |
1 |
756 |
DEVICE CONNECTION ISSUE |
1 |
757 |
DEVICE DISLOCATION |
1 |
758 |
DISABILITY |
1 |
759 |
DISABLED RELATIVE |
1 |
760 |
DISORGANISED SPEECH |
1 |
761 |
DIVERTICULITIS |
1 |
762 |
DIZZINESS POSTURAL |
1 |
763 |
DRUG EFFECT DELAYED |
1 |
764 |
DRUG EFFECT INCOMPLETE |
1 |
765 |
DRUG ERUPTION |
1 |
766 |
DRUG INTOLERANCE |
1 |
767 |
DRUG LEVEL ABNORMAL |
1 |
768 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
769 |
DRUG-INDUCED LIVER INJURY |
1 |
770 |
DUODENAL STENOSIS |
1 |
771 |
DYSAESTHESIA |
1 |
772 |
DYSMENORRHOEA |
1 |
773 |
DYSPAREUNIA |
1 |
774 |
DYSPNOEA EXERTIONAL |
1 |
775 |
DYSTONIA |
1 |
776 |
EAR DISORDER |
1 |
777 |
EAR INFECTION |
1 |
778 |
ECCHYMOSIS |
1 |
779 |
EMBOLIC STROKE |
1 |
780 |
EMBOLISM |
1 |
781 |
ENDOCARDITIS FIBROPLASTICA |
1 |
782 |
ENDOCRINE DISORDER |
1 |
783 |
ENDOTHELIAL DYSFUNCTION |
1 |
784 |
ENERGY INCREASED |
1 |
785 |
ENTEROCOCCAL INFECTION |
1 |
786 |
EOSINOPHIL COUNT DECREASED |
1 |
787 |
EXOPHTHALMOS |
1 |
788 |
EXPOSURE DURING BREAST FEEDING |
1 |
789 |
EXPOSURE DURING PREGNANCY |
1 |
790 |
EXPOSURE VIA BREAST MILK |
1 |
791 |
EXPOSURE VIA DIRECT CONTACT |
1 |
792 |
EXPOSURE VIA EYE CONTACT |
1 |
793 |
EXTRASYSTOLES |
1 |
794 |
EXTREMITY CONTRACTURE |
1 |
795 |
EYE CONTUSION |
1 |
796 |
EYE OEDEMA |
1 |
797 |
EYELID PAIN |
1 |
798 |
FACIAL BONES FRACTURE |
1 |
799 |
FACIAL DISCOMFORT |
1 |
800 |
FACIAL PARALYSIS |
1 |
801 |
FAECAL INCONTINENCE |
1 |
802 |
FAILURE TO THRIVE |
1 |
803 |
FANCONI SYNDROME ACQUIRED |
1 |
804 |
FEELING DRUNK |
1 |
805 |
FEELING JITTERY |
1 |
806 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
807 |
FIBROMYALGIA |
1 |
808 |
FISTULA |
1 |
809 |
FLUID RETENTION |
1 |
810 |
FOETAL GROWTH ABNORMALITY |
1 |
811 |
FOOD ALLERGY |
1 |
812 |
FOOD AVERSION |
1 |
813 |
FRACTURE |
1 |
814 |
FREQUENT BOWEL MOVEMENTS |
1 |
815 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
816 |
FUNGAL INFECTION |
1 |
817 |
FUNGAL OESOPHAGITIS |
1 |
818 |
GALLBLADDER OEDEMA |
1 |
819 |
GASTRIC DISORDER |
1 |
820 |
GASTROENTERITIS BACTERIAL |
1 |
821 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
822 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
823 |
GENERALISED OEDEMA |
1 |
824 |
GLARE |
1 |
825 |
GLAUCOMA |
1 |
826 |
GLIOBLASTOMA MULTIFORME |
1 |
827 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
828 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
829 |
GLUTEN SENSITIVITY |
1 |
830 |
HAEMODYNAMIC INSTABILITY |
1 |
831 |
HAEMORRHAGE INTRACRANIAL |
1 |
832 |
HAEMORRHAGIC DIATHESIS |
1 |
833 |
HAIR COLOUR CHANGES |
1 |
834 |
HAIR DISORDER |
1 |
835 |
HAIR TEXTURE ABNORMAL |
1 |
836 |
HALO VISION |
1 |
837 |
HAND-ARM VIBRATION SYNDROME |
1 |
838 |
HANGOVER |
1 |
839 |
HEAD BANGING |
1 |
840 |
HEAVY METAL INCREASED |
1 |
841 |
HEPATIC CYST |
1 |
842 |
HEPATIC ENZYME INCREASED |
1 |
843 |
HEPATIC FUNCTION ABNORMAL |
1 |
844 |
HEPATOBILIARY DISEASE |
1 |
845 |
HIP FRACTURE |
1 |
846 |
HISTAMINE INTOLERANCE |
1 |
847 |
HORMONE LEVEL ABNORMAL |
1 |
848 |
HOSPITALISATION |
1 |
849 |
HYPERAEMIA |
1 |
850 |
HYPERCALCAEMIA |
1 |
851 |
HYPEREOSINOPHILIC SYNDROME |
1 |
852 |
HYPERKALAEMIA |
1 |
853 |
HYPERKERATOSIS |
1 |
854 |
HYPERNATRAEMIA |
1 |
855 |
HYPERPHOSPHATAEMIA |
1 |
856 |
HYPERTHERMIA |
1 |
857 |
HYPERTRANSAMINASAEMIA |
1 |
858 |
HYPOACUSIS |
1 |
859 |
HYPOKINESIA |
1 |
860 |
HYPONATRAEMIA |
1 |
861 |
HYPOPERFUSION |
1 |
862 |
HYPOPHOSPHATAEMIA |
1 |
863 |
HYPOPNOEA |
1 |
864 |
HYPOREFLEXIA |
1 |
865 |
HYPOTHYROIDISM |
1 |
866 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
867 |
IATROGENIC INJURY |
1 |
868 |
ILEUS |
1 |
869 |
IMMEDIATE POST-INJECTION REACTION |
1 |
870 |
IMMOBILE |
1 |
871 |
IMMUNE SYSTEM DISORDER |
1 |
872 |
IMPAIRED DRIVING ABILITY |
1 |
873 |
IMPAIRED GASTRIC EMPTYING |
1 |
874 |
IMPAIRED SELF-CARE |
1 |
875 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
876 |
INCORRECT DOSAGE ADMINISTERED |
1 |
877 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
878 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
1 |
879 |
INFLAMMATORY MARKER INCREASED |
1 |
880 |
INFLUENZA |
1 |
881 |
INITIAL INSOMNIA |
1 |
882 |
INJECTION SITE BRUISING |
1 |
883 |
INJECTION SITE DISCOLOURATION |
1 |
884 |
INJECTION SITE HAEMORRHAGE |
1 |
885 |
INJECTION SITE HYPOAESTHESIA |
1 |
886 |
INJECTION SITE INFLAMMATION |
1 |
887 |
INJECTION SITE INJURY |
1 |
888 |
INJECTION SITE NODULE |
1 |
889 |
INJECTION SITE PHLEBITIS |
1 |
890 |
INJECTION SITE REACTION |
1 |
891 |
INJECTION SITE THROMBOSIS |
1 |
892 |
INJECTION SITE URTICARIA |
1 |
893 |
INJURY ASSOCIATED WITH DEVICE |
1 |
894 |
INTELLIGENCE TEST ABNORMAL |
1 |
895 |
INTENTION TREMOR |
1 |
896 |
INTERCEPTED MEDICATION ERROR |
1 |
897 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
898 |
INTESTINAL STENOSIS |
1 |
899 |
JAW DISORDER |
1 |
900 |
JOINT CONTRACTURE |
1 |
901 |
JOINT CREPITATION |
1 |
902 |
JOINT DISLOCATION |
1 |
903 |
JOINT INSTABILITY |
1 |
904 |
JOINT LOCK |
1 |
905 |
JOINT NOISE |
1 |
906 |
JUGULAR VEIN THROMBOSIS |
1 |
907 |
KIDNEY MALROTATION |
1 |
908 |
LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR |
1 |
909 |
LACERATION |
1 |
910 |
LANGUAGE DISORDER |
1 |
911 |
LARYNGEAL DISCOMFORT |
1 |
912 |
LARYNGITIS |
1 |
913 |
LIBIDO DECREASED |
1 |
914 |
LICHENOID KERATOSIS |
1 |
915 |
LIP OEDEMA |
1 |
916 |
LIP PAIN |
1 |
917 |
LIVEDO RETICULARIS |
1 |
918 |
LIVER FUNCTION TEST ABNORMAL |
1 |
919 |
LIVER FUNCTION TEST INCREASED |
1 |
920 |
LOCAL SWELLING |
1 |
921 |
LOCALISED OEDEMA |
1 |
922 |
LOSS OF BLADDER SENSATION |
1 |
923 |
LYME DISEASE |
1 |
924 |
LYMPHADENOPATHY |
1 |
925 |
LYMPHOCYTE COUNT DECREASED |
1 |
926 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
927 |
LYMPHOEDEMA |
1 |
928 |
MACULE |
1 |
929 |
MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE |
1 |
930 |
MASS |
1 |
931 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
932 |
MEAN PLATELET VOLUME DECREASED |
1 |
933 |
MELAENA |
1 |
934 |
MENINGEAL DISORDER |
1 |
935 |
MENINGITIS ASEPTIC |
1 |
936 |
MENINGITIS CHEMICAL |
1 |
937 |
MENORRHAGIA |
1 |
938 |
MENSTRUATION IRREGULAR |
1 |
939 |
MENTAL DISORDER |
1 |
940 |
MENTAL FATIGUE |
1 |
941 |
METASTASES TO LYMPH NODES |
1 |
942 |
METASTASES TO MENINGES |
1 |
943 |
MICTURITION URGENCY |
1 |
944 |
MONOPLEGIA |
1 |
945 |
MOTOR DYSFUNCTION |
1 |
946 |
MOUTH HAEMORRHAGE |
1 |
947 |
MUCOSAL DRYNESS |
1 |
948 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
949 |
MULTIPLE SCLEROSIS |
1 |
950 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
951 |
MUSCLE CONTRACTURE |
1 |
952 |
MUSCLE DISCOMFORT |
1 |
953 |
MUSCLE DISORDER |
1 |
954 |
MUSCLE INJURY |
1 |
955 |
MUSCLE RIGIDITY |
1 |
956 |
MUSCLE SPASTICITY |
1 |
957 |
MUSCLE STRENGTH ABNORMAL |
1 |
958 |
MUSCLE SWELLING |
1 |
959 |
MUSCLE TONE DISORDER |
1 |
960 |
MYELOFIBROSIS |
1 |
961 |
MYOCARDITIS |
1 |
962 |
MYOCLONUS |
1 |
963 |
NAIL DISCOLOURATION |
1 |
964 |
NAIL DISORDER |
1 |
965 |
NEOPLASM |
1 |
966 |
NEOPLASM PROGRESSION |
1 |
967 |
NEOPLASM SKIN |
1 |
968 |
NEPHRITIS |
1 |
969 |
NEPHROPATHY TOXIC |
1 |
970 |
NEPHROTIC SYNDROME |
1 |
971 |
NERVE INJURY |
1 |
972 |
NEUROLOGICAL DECOMPENSATION |
1 |
973 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
974 |
NIGHT SWEATS |
1 |
975 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
976 |
OCCIPITAL NEURALGIA |
1 |
977 |
ODYNOPHAGIA |
1 |
978 |
OEDEMA GENITAL |
1 |
979 |
OESOPHAGEAL PAIN |
1 |
980 |
OESOPHAGEAL SPASM |
1 |
981 |
OLIGOHYDRAMNIOS |
1 |
982 |
OLIGURIA |
1 |
983 |
ONYCHOCLASIS |
1 |
984 |
ORAL MUCOSAL ERUPTION |
1 |
985 |
OROMANDIBULAR DYSTONIA |
1 |
986 |
OSTEITIS |
1 |
987 |
OSTEOARTHRITIS |
1 |
988 |
OSTEOMYELITIS |
1 |
989 |
OSTEOSCLEROSIS |
1 |
990 |
OTORRHOEA |
1 |
991 |
OVARIAN CANCER |
1 |
992 |
OVARIAN CANCER STAGE III |
1 |
993 |
OXYGEN SATURATION ABNORMAL |
1 |
994 |
PANCREATIC FISTULA |
1 |
995 |
PANCREATITIS RELAPSING |
1 |
996 |
PARANASAL SINUS DISCOMFORT |
1 |
997 |
PARANASAL SINUS HYPERSECRETION |
1 |
998 |
PARAPLEGIA |
1 |
999 |
PARESIS |
1 |